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Figure 1. Schematic representation of Eculizumab inhibiting the cleavage of 
C5, preventing the formation of C5a and the membrane attack complex.
Table 1. Laboratory Data Demonstrating Renal and Hematologic Parameters







 09/16/2013 0.64 10.9 220 17 22 Neg Blood, Neg Protein 5.1
14:14 09/20/2013  11.9 224 270mg (24hr)             0.9
00:05 09/21/2013  6.8
07:15  09/21/2013  5.2 124 1
11:05 09/21/2013 2.47 5.7 118 898 Prot+1, blood +5 rbc 5:15 0.7 207 <40 18
18:00 09/21/2013 2.88 7.1 53 1607 19
22:05 09/21/2013 3.63 2011 210 118 8 1
(TPE Provided)
04:10 09/22/2013 4.09 6 81 984 89 48 1.2 74 3.60%
11:50 09/22/2013 5.15 6.2 77 1098 0.9 413
18:30 09/22/2013  6.4 79 564 48 104
(HD and TPE) Provided





























Figure 2a. Light Microscopy 
demonstrating acute fibrin thrombus.
Figure 2b. Light Microscopy 
demonstrating organizing thrombus.
Figure 2c. Electron Microscopy.
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